The Integrative Human Microbiome Project: Dynamic Analysis of Microbiome-Host Omics Profiles during Periods of Human Health and Disease

Abstract

Much has been learned about the diversity and distribution of human-associated microbial communities, but we still know little about the biology of the microbiome, how it interacts with the host, and how the host responds to its resident microbiota. The Integrative Human Microbiome Project (iHMP, http://hmp2.org), the second phase of the NIH Human Microbiome Project, will study these interactions by analyzing microbiome and host activities in longitudinal studies of disease-specific cohorts and by creating integrated data sets of microbiome and host functional properties. These data sets will serve as experimental test beds to evaluate new models, methods, and analyses on the interactions of host and microbiome. Here we describe the three models of microbiome-associated human conditions, on the dynamics of preterm birth, inflammatory bowel disease, and type 2 diabetes, and their underlying hypotheses, as well as the multi-omic data types to be collected, integrated, and distributed through public repositories as a community resource.

References 76

1. 1.
   A Metagenomic Approach to Characterization of the Vaginal Microbiome Signature in Pregnancy · 2012

   No notice
2. 2.

   Abraham C, Cho JH. Inflammatory bowel disease. N Engl J Med. 2009;361:2066-2078.

   Not in our library10.1056/nejmra0804647

3. 3.
   Metabolic Reconstruction for Metagenomic Data and Its Application to the Human Microbiome · 2012

   No notice
4. 4.

   Akash MS, Rehman K, Chen S. An overview of valuable scientific models for diabetes mellitus. Curr Diabetes Rev. 2013;9:286-293.

   Not in our library10.2174/15733998113099990062

5. 5.

   Alves JM, Buck GA. Automated system for gene annotation and metabolic pathway reconstruction using general sequence databases. Chem Biodivers. 2007;4:2593-2602.

   Not in our library10.1002/cbdv.200790212

6. 6.

   Economic costs of diabetes in the U.S. In 2007. Diabetes Care. 2008;31:596-615.

   Not in our library10.2337/dc08-9017

7. 7.

   Ananthakrishnan AN, Huang H, Nguyen DD, Sauk J, Yajnik V, Xavier RJ. Differential effect of genetic burden on disease phenotypes in Crohn’s disease and ulcerative colitis: analysis of a North American cohort. Am J Gastroenterol. 2014;109:395-400.

   Not in our library10.1038/ajg.2013.464

8. 8.

   Baumgart DC, Sandborn WJ. Crohn’s disease. Lancet. 2012;380:1590-1605.

   Not in our library10.1016/s0140-6736(12)60026-9

9. 9.

   Behrman RE, Butler AS. Preterm Birth: Causes. 2007.

   Not in our library

10. 10.

    Cantarel BL, Erickson AR, VerBerkmoes NC, Erickson BK, Carey PA, Pan C, Shah M, Mongodin EF, Jansson JK, Fraser-Liggett CM, Hettich RL. Strategies for metagenomic-guided whole-community proteomics of complex microbial environments. PLoS ONE. 2011;6:e27173.

    Not in our library10.1371/journal.pone.0027173

11. 11.

    Chen R, Mias GI, Li-Pook-Than J, Jiang L, Lam HY, Chen R, Miriami E, Karczewski KJ, Hariharan M, Dewey FE, et al. Personal omics profiling reveals dynamic molecular and medical phenotypes. Cell. 2012;148:1293-1307.

    Not in our library10.1016/j.cell.2012.02.009

12. 12.

    Cohen S, Kamarck T, Mermelstein R. A global measure of perceived stress. J Health Soc Behav. 1983;24:385-396.

    Not in our library

13. 13.

    Danese S, Fiocchi C. Ulcerative colitis. N Engl J Med. 2011;365:1713-1725.

    Not in our library10.1056/nejmra1102942

14. 14.

    de Weerth C, Fuentes S, de Vos WM. Crying in infants: on the possible role of intestinal microbiota in the development of colic. Gut Microbes. 2013;4:416-421.

    Not in our library10.4161/gmic.26041

15. 15.

    Dethlefsen L, Eckburg PB, Bik EM, Relman DA. Assembly of the human intestinal microbiota. Trends Ecol Evol. 2006;21:517-523.

    Not in our library10.1016/j.tree.2006.06.013

16. 16.

    Dicksved J, Halfvarson J, Rosenquist M, Järnerot G, Tysk C, Apajalahti J, Engstrand L, Jansson JK. Molecular analysis of the gut microbiota of identical twins with Crohn’s disease. ISME J. 2008;2:716-727.

    Not in our library10.1038/ismej.2008.37

17. 17.
    Integrated Metagenomics/Metaproteomics Reveals Human Host-Microbiota Signatures of Crohn's Disease · 2012

    No notice
18. 18.

    Esser N, Legrand-Poels S, Piette J, Scheen AJ, Paquot N. Inflammation as a link between obesity, metabolic syndrome and type 2 diabetes. Diabetes Res Clin Pract. 2014;105:141-150.

    Not in our library10.1016/j.diabres.2014.04.006

19. 19.
    Species-level classification of the vaginal microbiome · 2012

    No notice
20. 20.

    Frank DN, St Amand AL, Feldman RA, Boedeker EC, Harpaz N, Pace NR. Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases. Proc Natl Acad Sci USA. 2007;104:13780-13785.

    Not in our library10.1073/pnas.0706625104

21. 21.

    Franzosa EA, Morgan XC, Segata N, Waldron L, Reyes J, Earl AM, Giannoukos G, Boylan MR, Ciulla D, Gevers D, et al. Relating the metatranscriptome and metagenome of the human gut. Proc Natl Acad Sci USA. 2014;111:E2329-E2338.

    Not in our library10.1073/pnas.1319284111

22. 22.

    Friedrich N. Metabolomics in diabetes research. J Endocrinol. 2012;215:29-42.

    Not in our library10.1530/joe-12-0120

23. 23.

    Gallo RL, Hooper LV. Epithelial antimicrobial defence of the skin and intestine. Nat Rev Immunol. 2012;12:503-516.

    Not in our library10.1038/nri3228

24. 24.
    The Human Microbiome Project: A Community Resource for the Healthy Human Microbiome · 2012

    No notice
25. 25.

    Gevers D, Kugathasan S, Denson LA, Vázquez-Baeza Y, Van Treuren W, Ren B, Schwager E, Knights D, Song SJ, Yassour M, et al. The treatment-naive microbiome in new-onset Crohn’s disease. Cell Host Microbe. 2014;15:382-392.

    Not in our library10.1016/j.chom.2014.02.005

26. 26.

    Goldenberg RL, Hauth JC, Andrews WW. Intrauterine infection and preterm delivery. N Engl J Med. 2000;342:1500-1507.

    Not in our library10.1056/nejm200005183422007

27. 27.

    Hallal PC, Victora CG. Reliability and validity of the International Physical Activity Questionnaire (IPAQ). Med Sci Sports Exerc. 2004;36:556.

    Not in our library10.1249/01.mss.0000117161.66394.07

28. 28.

    Harwich MD, Serrano MG, Fettweis JM, Alves JM, Reimers MA, Vaginal Microbiome Consortium (additional members), Buck GA, Jefferson KK. Genomic sequence analysis and characterization of Sneathia amnii sp.nov. BMC Genomics. 2012;13(Suppl 8):S4.

    Not in our library10.1186/1471-2164-13-s8-s4

29. 29.

    Hooper LV, Gordon JI. Commensal host-bacterial relationships in the gut. Science. 2001;292:1115-1118.

    Not in our library10.1126/science.1058709

30. 30.

    Hudson ME, Pozdnyakova I, Haines K, Mor G, Snyder M. Identification of differentially expressed proteins in ovarian cancer using high-density protein microarrays. Proc Natl Acad Sci USA. 2007;104:17494-17499.

    Not in our library10.1073/pnas.0708572104

31. 31.

    A framework for human microbiome research. Nature. 2012a;486:215-221.

    Not in our library10.1038/nature11209

32. 32.

    Structure, function and diversity of the healthy human microbiome. Nature. 2012b;486:207-214.

    Not in our library10.1038/nature11234

33. 33.

    Joossens M, Huys G, Cnockaert M, De Preter V, Verbeke K, Rutgeerts P, Vandamme P, Vermeire S. Dysbiosis of the faecal microbiota in patients with Crohn’s disease and their unaffected relatives. Gut. 2011;60:631-637.

    Not in our library10.1136/gut.2010.223263

34. 34.

    Khor B, Gardet A, Xavier RJ. Genetics and pathogenesis of inflammatory bowel disease. Nature. 2011;474:307-317.

    Not in our library10.1038/nature10209

35. 35.

    Koren O, Goodrich JK, Cullender TC, Spor A, Laitinen K, Bäckhed HK, Gonzalez A, Werner JJ, Angenent LT, Knight R, et al. Host remodeling of the gut microbiome and metabolic changes during pregnancy. Cell. 2012;150:470-480.

    Not in our library10.1016/j.cell.2012.07.008

36. 36.

    Lam HY, Pan C, Clark MJ, Lacroute P, Chen R, Haraksingh R, O’Huallachain M, Gerstein MB, Kidd JM, Bustamante CD, Snyder M. Detecting and annotating genetic variations using the HugeSeq pipeline. Nat Biotechnol. 2012;30:226-229.

    Not in our library10.1038/nbt.2134

37. 37.

    Loftus EV. Clinical epidemiology of inflammatory bowel disease: Incidence, prevalence, and environmental influences. Gastroenterology. 2004;126:1504-1517.

    Not in our library10.1053/j.gastro.2004.01.063

38. 38.

    Maier T, Güell M, Serrano L. Correlation of mRNA and protein in complex biological samples. FEBS Lett. 2009;583:3966-3973.

    Not in our library10.1016/j.febslet.2009.10.036

39. 39.

    Manichanh C, Rigottier-Gois L, Bonnaud E, Gloux K, Pelletier E, Frangeul L, Nalin R, Jarrin C, Chardon P, Marteau P, et al. Reduced diversity of faecal microbiota in Crohn’s disease revealed by a metagenomic approach. Gut. 2006;55:205-211.

    Not in our library10.1136/gut.2005.073817

40. 40.

    Martin J, Sykes S, Young S, Kota K, Sanka R, Sheth N, Orvis J, Sodergren E, Wang Z, Weinstock GM, Mitreva M. Optimizing read mapping to reference genomes to determine composition and species prevalence in microbial communities. PLoS ONE. 2012;7:e36427.

    Not in our library10.1371/journal.pone.0036427

41. 41.

    Maurice CF, Haiser HJ, Turnbaugh PJ. Xenobiotics shape the physiology and gene expression of the active human gut microbiome. Cell. 2013;152:39-50.

    Not in our library10.1016/j.cell.2012.10.052

42. 42.

    Maynard CL, Elson CO, Hatton RD, Weaver CT. Reciprocal interactions of the intestinal microbiota and immune system. Nature. 2012;489:231-241.

    Not in our library10.1038/nature11551

43. 43.
    Integrative analysis of the microbiome and metabolome of the human intestinal mucosal surface reveals exquisite inter-relationships · 2013

    No notice
44. 44.

    Meyer F, Trimble WL, Chang EB, Handley KM. Functional predictions from inference and observation in sequence-based inflammatory bowel disease research. Genome Biol. 2012;13:169.

    Not in our library10.1186/gb-2012-13-9-169

45. 45.

    Molodecky NA, Panaccione R, Ghosh S, Barkema HW, Kaplan GG, Alberta Inflammatory Bowel Disease Consortium. Challenges associated with identifying the environmental determinants of the inflammatory bowel diseases. Inflamm Bowel Dis. 2011;17:1792-1799.

    Not in our library10.1002/ibd.21511

46. 46.
    Dysfunction of the intestinal microbiome in inflammatory bowel disease and treatment · 2012

    No notice
47. 47.

    Ordás I, Eckmann L, Talamini M, Baumgart DC, Sandborn WJ. Ulcerative colitis. Lancet. 2012;380:1606-1619.

    Not in our library10.1016/s0140-6736(12)60150-0

48. 48.

    Ott SJ, Musfeldt M, Wenderoth DF, Hampe J, Brant O, Fölsch UR, Timmis KN, Schreiber S. Reduction in diversity of the colonic mucosa associated bacterial microflora in patients with active inflammatory bowel disease. Gut. 2004;53:685-693.

    Not in our library10.1136/gut.2003.025403

49. 49.

    Packey CD, Sartor RB. Commensal bacteria, traditional and opportunistic pathogens, dysbiosis and bacterial killing in inflammatory bowel diseases. Curr Opin Infect Dis. 2009;22:292-301.

    Not in our library10.1097/qco.0b013e32832a8a5d

50. 50.

    Presley LL, Ye J, Li X, Leblanc J, Zhang Z, Ruegger PM, Allard J, Mc-Govern D, Ippoliti A, Roth B, et al. Host-microbe relationships in inflammatory bowel disease detected by bacterial and metaproteomic analysis of the mucosal-luminal interface. Inflamm Bowel Dis. 2012;18:409-417.

    Not in our library10.1002/ibd.21793

51. 51.

    Prince AL, Antony KM, Ma J, Aagaard KM. The microbiome and development: a mother’s perspective. Semin Reprod Med. 2014;32:14-22.

    Not in our library10.1055/s-0033-1361818

52. 52.

    Qin J, Li R, Raes J, Arumugam M, Burgdorf KS, Manichanh C, Nielsen T, Pons N, Levenez F, Yamada T, et al. A human gut microbial gene catalogue established by metagenomic sequencing. Nature. 2010;464:59-65.

    Not in our library10.1038/nature08821

53. 53.

    Qin J, Li Y, Cai Z, Li S, Zhu J, Zhang F, Liang S, Zhang W, Guan Y, Shen D, et al. A metagenome-wide association study of gut microbiota in type 2 diabetes. Nature. 2012;490:55-60.

    Not in our library10.1038/nature11450

54. 54.

    Ratner RE, Diabetes Prevention Program Research. An update on the Diabetes Prevention Program. Endocr Pract. 2006;12(Suppl 1):20-24.

    Not in our library10.4158/ep.12.s1.20

55. 55.

    Renz H, von Mutius E, Brandtzaeg P, Cookson WO, Autenrieth IB, Haller D. Gene-environment interactions in chronic inflammatory disease. Nat Immunol. 2011;12:273-277.

    Not in our library10.1038/ni0411-273

56. 56.
    The vaginal microbiota of pregnant women who subsequently have spontaneous preterm labor and delivery and those with a normal delivery at term · 2014

    No notice
57. 57.
    The composition and stability of the vaginal microbiota of normal pregnant women is different from that of non-pregnant women · 2014

    Corrected
58. 58.

    Savage DC. Microbial ecology of the gastrointestinal tract. Annu Rev Microbiol. 1977;31:107-133.

    Not in our library10.1146/annurev.mi.31.100177.000543

59. 59.

    Scanlan PD, Shanahan F, O’Mahony C, Marchesi JR. Culture-independent analyses of temporal variation of the dominant fecal microbiota and targeted bacterial subgroups in Crohn’s disease. J Clin Microbiol. 2006;44:3980-3988.

    Not in our library10.1128/jcm.00312-06

60. 60.

    Schloissnig S, Arumugam M, Sunagawa S, Mitreva M, Tap J, Zhu A, Waller A, Mende DR, Kultima JR, Martin J, et al. Genomic variation landscape of the human gut microbiome. Nature. 2013;493:45-50.

    Not in our library10.1038/nature11711

61. 61.

    Shu CJ, Benoist C, Mathis D. The immune system’s involvement in obesity-driven type 2 diabetes. Semin Immunol. 2012;24:436-442.

    Not in our library10.1016/j.smim.2012.12.001

62. 62.

    Sokol H, Lay C, Seksik P, Tannock GW. Analysis of bacterial bowel communities of IBD patients: what has it revealed? Inflamm Bowel Dis. 2008;14:858-867.

    Not in our library10.1002/ibd.20392

63. 63.

    Sokol H, Seksik P, Furet JP, Firmesse O, Nion-Larmurier I, Beaugerie L, Cosnes J, Corthier G, Marteau P, Doré J. Low counts of Faecalibacterium prausnitzii in colitis microbiota. Inflamm Bowel Dis. 2009;15:1183-1189.

    Not in our library10.1002/ibd.20903

64. 64.

    Stappenbeck TS, Wong MH, Saam JR, Mysorekar IU, Gordon JI. Notes from some crypt watchers: regulation of renewal in the mouse intestinal epithelium. Curr Opin Cell Biol. 1998;10:702-709.

    Not in our library10.1016/s0955-0674(98)80110-5

65. 65.
    A Modular Organization of the Human Intestinal Mucosal Microbiota and Its Association with Inflammatory Bowel Disease · 2013

    No notice
66. 66.

    Turnbaugh PJ, Ley RE, Mahowald MA, Magrini V, Mardis ER, Gordon JI. An obesity-associated gut microbiome with increased capacity for energy harvest. Nature. 2006;444:1027-1031.

    Not in our library10.1038/nature05414

67. 67.

    Turnbaugh PJ, Ridaura VK, Faith JJ, Rey FE, Knight R, Gordon JI. The effect of diet on the human gut microbiome: a metagenomic analysis in humanized gnotobiotic mice. Sci Transl Med. 2009;1:ra14.

    Not in our library10.1126/scitranslmed.3000322

68. 68.

    Walters TD, Kim MO, Denson LA, Griffiths AM, Dubinsky M, Markowitz J, Baldassano R, Crandall W, Rosh J, Pfefferkorn M, et al. Increased effectiveness of early therapy with anti-tumor necrosis factor-a vs an immunomodulator in children with Crohn’s disease. Gastroenterology. 2014;146:383-391.

    Not in our library10.1053/j.gastro.2013.10.027

69. 69.

    Wang Q, Garrity GM, Tiedje JM, Cole JR. Naive Bayesian classifier for rapid assignment of rRNA sequences into the new bacterial taxonomy. Appl Environ Microbiol. 2007;73:5261-5267.

    Not in our library10.1128/aem.00062-07

70. 70.

    Wijesinghe DS, Allegood JC, Gentile LB, Fox TE, Kester M, Chalfant CE. Use of high performance liquid chromatography-electrospray ionization-tandem mass spectrometry for the analysis of ceramide-1-phosphate levels. J Lipid Res. 2010;51:641-651.

    Not in our library10.1194/jlr.d000430

71. 71.

    Wijesinghe DS, Mayton EK, Mietla JA, Mukherjee A, Wu J, Fang X, Chalfant CE. Characterization of lysophosphatidic acid subspecies produced by autotaxin using a modified HPLC ESI-MS/MS method. Anal Methods. 2011;3:2822-2828.

    Not in our library10.1039/c1ay05459g

72. 72.

    Willing B, Halfvarson J, Dicksved J, Rosenquist M, Järnerot G, Eng-strand L, Tysk C, Jansson JK. Twin studies reveal specific imbalances in the mucosa-associated microbiota of patients with ileal Crohn’s disease. Inflamm Bowel Dis. 2009;15:653-660.

    Not in our library10.1002/ibd.20783

73. 73.

    Willing BP, Dicksved J, Halfvarson J, Andersson AF, Lucio M, Zheng Z, Järnerot G, Tysk C, Jansson JK, Engstrand L. A pyrosequencing study in twins shows that gastrointestinal microbial profiles vary with inflammatory bowel disease phenotypes. Gastroenterology. 2010;139:1844-1854.e1.

    Not in our library10.1053/j.gastro.2010.08.049

74. 74.
    Sequence Analysis of the Human Virome in Febrile and Afebrile Children · 2012

    No notice
75. 75.

    Wylie KM, Weinstock GM, Storch GA. Emerging view of the human virome. Transl Res. 2012b;160:283-290.

    Not in our library10.1016/j.trsl.2012.03.006

76. 76.

    Xavier RJ, Podolsky DK. Unravelling the pathogenesis of inflammatory bowel disease. Nature. 2007;448:427-434.

    Not in our library10.1038/nature06005

Cited by papers we hold 31

• A systematic framework for understanding the microbiome in human health and disease: from basic principles to clinical translation · 2024
  No notice
• Multi-Omics Profiling for Health · 2023
  No notice
• Drug-microbiota interactions: an emerging priority for precision medicine · 2023
  No notice
• Ecosystem-specific microbiota and microbiome databases in the era of big data · 2022
  Not checked
• Microbiome and Human Health: Current Understanding, Engineering, and Enabling Technologies · 2022
  No notice
• Computational methods for chromosome-scale haplotype reconstruction · 2021
  Not checked
• Effects of Rare Microbiome Taxa Filtering on Statistical Analysis · 2021
  No notice
• Gut microbial co-abundance networks show specificity in inflammatory bowel disease and obesity · 2020
  No notice
• The Human Oral Microbiome in Health and Disease: From Sequences to Ecosystems · 2020
  No notice
• Baseline human gut microbiota profile in healthy people and standard reporting template · 2019
  No notice
• Current and Future Approaches for Monitoring Responses to Anti-complement Therapeutics · 2019
  Not checked
• The Integrative Human Microbiome Project · 2019
  No notice
• The Role of the Gut Microbiota in Lipid and Lipoprotein Metabolism · 2019
  No notice
• Predictive metabolomic profiling of microbial communities using amplicon or metagenomic sequences · 2019
  No notice
• Fecal pollution can explain antibiotic resistance gene abundances in anthropogenically impacted environments · 2019
  No notice
• A review of 10 years of human microbiome research activities at the US National Institutes of Health, Fiscal Years 2007-2016 · 2019
  No notice
• Exploring the emerging role of the microbiome in cancer immunotherapy · 2019
  No notice
• Microbiome Multi-Omics Network Analysis: Statistical Considerations, Limitations, and Opportunities · 2019
  No notice
• The vaginal microbiome and preterm birth · 2019
  No notice
• Longitudinal multi-omics of host–microbe dynamics in prediabetes · 2019
  No notice

and 11 more

Reads

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.